Key 3 Portfolio, Series 26
Ticker Symbol: FGYGLX
30 Holdings (As of Day of Deposit) |
Ticker |
Compant Name |
Initial
Weight |
Price* |
Communication Services |
GOOG |
Alphabet Inc. |
3.35% |
$173.56 |
EA |
Electronic Arts Inc. |
3.30% |
131.23 |
META |
Meta Platforms Inc. |
3.28% |
467.05 |
NFLX |
Netflix, Inc. |
3.41% |
647.66 |
OMC |
Omnicom Group Inc. |
3.34% |
90.72 |
SPOT |
Spotify Technology S.A. |
3.39% |
304.69 |
TMUS |
T-Mobile US, Inc. |
3.29% |
170.70 |
TTWO |
Take-Two Interactive Software, Inc. |
3.36% |
159.78 |
TTD |
The Trade Desk, Inc. |
3.34% |
93.71 |
DIS |
The Walt Disney Company |
3.33% |
101.70 |
Health Care |
BSX |
Boston Scientific Corporation |
3.33% |
75.00 |
COR |
Cencora Inc. |
3.35% |
220.53 |
ELV |
Elevance Health Inc. |
3.26% |
507.34 |
HCA |
HCA Healthcare, Inc. |
3.33% |
335.10 |
MCK |
McKesson Corporation |
3.28% |
560.96 |
MRK |
Merck & Co., Inc. |
3.35% |
124.53 |
REGN |
Regeneron Pharmaceuticals, Inc. |
3.40% |
969.91 |
TMO |
Thermo Fisher Scientific Inc. |
3.29% |
562.76 |
UNH |
UnitedHealth Group Incorporated |
3.38% |
481.65 |
VRTX |
Vertex Pharmaceuticals Incorporated |
3.37% |
443.05 |
Information Technology |
ADBE |
Adobe Incorporated |
3.39% |
445.87 |
AAPL |
Apple Inc. |
3.36% |
191.29 |
AMAT |
Applied Materials, Inc. |
3.29% |
216.54 |
ANET |
Arista Networks, Inc. |
3.37% |
303.66 |
AVGO |
Broadcom Inc. |
3.19% |
1,364.08 |
MSFT |
Microsoft Corporation |
3.39% |
414.67 |
NVDA |
NVIDIA Corporation |
3.23% |
1,105.00 |
QCOM |
QUALCOMM Incorporated |
3.35% |
204.80 |
CRM |
Salesforce, Inc. |
3.31% |
218.01 |
NOW |
ServiceNow, Inc. |
3.39% |
643.29 |
*As of the close of business on 5/30/24.
Market values are for reference only and are not indicative of your individual
cost basis.
Not FDIC Insured Not Bank Guaranteed May Lose Value |
Portfolio Summary |
Initial Date of Deposit |
5/31/2024 |
Initial Public Offering Price |
$10.00 per Unit |
Portfolio Ending Date |
6/1/2026 |
Cash
CUSIP |
30335U148 |
Reinvestment
CUSIP |
30335U155 |
Fee Accounts Cash CUSIP |
30335U163 |
Fee Accounts Reinvestment CUSIP |
30335U171 |
Sales Charges (based on a $10 public offering
price) |
Standard Accounts |
Transactional Sales Charges |
Initial: |
0.00% |
|
Deferred: |
2.25% |
Creation & Development Fee (C&D Fee) |
|
0.50% |
Maximum Sales Charge |
|
2.75% |
Fee/Wrap Accounts |
Maximum Sales Charge |
|
0.50% |
The deferred sales charge will be deducted in three monthly installments commencing 9/20/24. When the
public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price
exceeds $10.00 per unit, you will pay an initial sales charge. The maximum sales charge for investors in fee
accounts consists of the C&D fee. Investors in fee accounts are not assessed any transactional sales charges.
Standard accounts sales charges apply to units purchased as an ineligible asset. The C&D fee is a charge of
$0.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10.00 per
unit, the C&D fee will be less than 0.50%; if the price you pay is less than $10.00 per unit, the C&D fee will
exceed 0.50%. In addition to the sales charges listed, UITs are subject to annual operating expenses and
organization costs.
You should consider the portfolio's investment objectives, risks, and
charges and expenses carefully before investing. Contact your financial professional
or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus,
which contains this and other information about the portfolio. Read it carefully
before you invest.
Risk Considerations
An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the
possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.
You should be aware that the portfolio is concentrated in stocks in the communication services, health care
and information technology sectors which involves additional risks, including limited diversification. The
companies engaged in the communication services sector are subject to rapidly changing technology, rapid
product obsolescence, loss of patent protection, cyclical market patterns, governmental regulation, evolving
industry standards and frequent new product introductions. Certain companies may be particularly susceptible
to cybersecurity threats, which could have an adverse effect on their business. The companies engaged in the
health care sector are subject to fierce competition, high research and development costs, governmental
regulations, loss of patent protection, and changing consumer spending trends. In addition, health crises, such
as a pandemic outbreak, can severely impact the health care industry in particular. The companies engaged in
the information technology sector are subject to fierce competition, high research and development costs, and
their products and services may be subject to rapid obsolescence. Technology company stocks, especially those
which are Internet-related, may experience extreme price and volume fluctuations that are often unrelated to
their operating performance.
Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and
exchange control restrictions impacting non-U.S. issuers.
Large capitalization companies may grow at a slower rate than the overall market.
As the use of Internet technology has become more prevalent in the course of business, the trust has become
more susceptible to potential operational risks through breaches in cybersecurity.
Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East have caused and could continue to cause significant market disruptions and volatility
within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.
The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease.
The value of the securities held by the trust may be subject to steep declines or increased volatility due to
changes in performance or perception of the issuers.
This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity.
There may be tax consequences unless units are purchased in an IRA or other qualified plan.